相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rates and impact of human antibody glycation in vivo
Andrew M. Goetze et al.
GLYCOBIOLOGY (2012)
C-Terminal Lysine Processing of Human Immunoglobulin G2 Heavy Chain In Vivo
Bing Cai et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Fragmentation of a Highly Purified Monoclonal Antibody Attributed to Residual CHO Cell Protease Activity
Sharon X. Gao et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies
Veysel Kayser et al.
BIOTECHNOLOGY JOURNAL (2011)
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
Sang Taek Jung et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
Andrew M. Goetze et al.
GLYCOBIOLOGY (2011)
Characterization of Site-Specific Glycation During Process Development of a Human Therapeutic Monoclonal Antibody
Amanda K. Miller et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Satish Kumar Singh
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
Weirong Wang et al.
MOLECULAR IMMUNOLOGY (2011)
Fragmentation of monoclonal antibodies
Josef Vlasak et al.
MABS (2011)
Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development
John den Engelsman et al.
PHARMACEUTICAL RESEARCH (2011)
Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
Miranda M. C. van Beers et al.
PHARMACEUTICAL RESEARCH (2011)
Prevalence and Isotypic Complexity of the Anti-Chinese Hamster Ovary Host Cell Protein Antibodies in Normal Human Serum
Li Xue et al.
AAPS JOURNAL (2010)
Characterization of trisulfide modification in antibodies
Sheng Gu et al.
ANALYTICAL BIOCHEMISTRY (2010)
Glycosylation of Therapeutic Proteins An Effective Strategy to Optimize Efficacy
Ricardo J. Sola et al.
BIODRUGS (2010)
Towards the Implementation of Quality by Design to the Production of Therapeutic Monoclonal Antibodies with Desired Glycosylation Patterns
Ioscani Jimenez del Val et al.
BIOTECHNOLOGY PROGRESS (2010)
Post-translational modifications of protein biopharmaceuticals
Gary Walsh
DRUG DISCOVERY TODAY (2010)
Protein aggregation-Pathways and influencing factors
Wei Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Highly glycosylated human alpha interferon: An insight into a new therapeutic candidate
Natalia Ceaglio et al.
JOURNAL OF BIOTECHNOLOGY (2010)
An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics
Satish K. Singh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
Damian Houde et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Endotoxin elimination in sepsis: physiology and therapeutic application
Klaus Buttenschoen et al.
LANGENBECKS ARCHIVES OF SURGERY (2010)
Naturally occurring glycan forms of human immunoglobulins G1 and G2
Gregory C. Flynn et al.
MOLECULAR IMMUNOLOGY (2010)
Assessing monoclonal antibody product quality attribute criticality through clinical studies
Andrew M. Goetze et al.
MABS (2010)
Stability of IgG isotypes in serum
Ivan R. Correia
MABS (2010)
Charge variants in IgG1 Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A. Khawli et al.
MABS (2010)
The immunogenicity of humanized and fully human antibodies Residual immunogenicity resides in the CDR regions
Fiona A. Harding et al.
MABS (2010)
Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice
Miranda M. C. van Beers et al.
PHARMACEUTICAL RESEARCH (2010)
In vitro methionine oxidation of escherichia coli-derived human stem cell factor: Effects on the molecular structure, biological activity, and dimerization
Yueh-Rong Hsu et al.
PROTEIN SCIENCE (2010)
Impact of Glycosylation on Effector Functions of Therapeutic IgG
Riad Abes et al.
PHARMACEUTICALS (2010)
Role of Glycosylation in Conformational Stability, Activity, Macromolecular Interaction and Immunogenicity of Recombinant Human Factor VIII
Matthew P. Kosloski et al.
AAPS JOURNAL (2009)
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
Josef Vlasak et al.
ANALYTICAL BIOCHEMISTRY (2009)
Human antibody Fc deamidation in vivo
Y. Diana Liu et al.
BIOLOGICALS (2009)
Degradation of an Fc-Fusion Recombinant Protein by Host Cell Proteases: Identification of a CHO Cathepsin D Protease
Flavie Robert et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
The effect of Fc glycan forms on human IgG2 antibody clearance in humans
Xiaoyu Chen et al.
GLYCOBIOLOGY (2009)
Immunogenicity of Aggregates of Recombinant Human Growth Hormone in Mouse Models
Amber Haynes Fradkin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality
John F. Carpenter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fcγ receptors
Andrea Bertolotti-Ciarlet et al.
MOLECULAR IMMUNOLOGY (2009)
Quality by design for biopharmaceuticals
Anurag S. Rathore et al.
NATURE BIOTECHNOLOGY (2009)
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn
Hai Pan et al.
PROTEIN SCIENCE (2009)
IgG glycosylation analysis
Carolin Huhn et al.
PROTEOMICS (2009)
Roadmap for implementation of quality by design (QbD) for biotechnology products
Anurag S. Rathore
TRENDS IN BIOTECHNOLOGY (2009)
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Royston Jefferis
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior
Cynthia Quan et al.
ANALYTICAL BIOCHEMISTRY (2008)
Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation
Dingjiang Liu et al.
BIOCHEMISTRY (2008)
Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content
Rodney Keck et al.
BIOLOGICALS (2008)
Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice
Thomas A. Millward et al.
BIOLOGICALS (2008)
C-terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes
Lawrence W. Dick et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Matthias Peipp et al.
BLOOD (2008)
Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities
Akito Natsume et al.
CANCER RESEARCH (2008)
Terminal sugars of Fc glycans influence antibody effector functions of IgGs
T. Shantha Raju
CURRENT OPINION IN IMMUNOLOGY (2008)
Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods
J. Vlasak et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Human IgG2 Antibody Disulfide Rearrangement in Vivo
Y. Diana Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G
Georgeen Gaza-Bulseco et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
The role of advanced glycation end products in progression and complications of diabetes
Su-Yen Goh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity
Douglas D. Banks et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Heterogeneity of monoclonal antibodies
Hongcheng Liu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
The function of the human interferon-β1a glycan determined in vivo
Lasse Dissing-Olesen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Post-translational modifications of recombinant proteins: Significance for biopharmaceuticals
Nigel Jenkins et al.
MOLECULAR BIOTECHNOLOGY (2008)
Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose
Christine H. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
Stephen L. Sazinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides
Johannes Stadlmann et al.
PROTEOMICS (2008)
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc
Robert M. Anthony et al.
SCIENCE (2008)
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function
Quin Zhou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
The glycosylation and pharmacokinetics of CTLA4Ig produced in rice cells
Hyoung Jin Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Preclinical and clinical safety of monoclonal antibodies
Mohammad A. Tabrizi et al.
DRUG DISCOVERY TODAY (2007)
Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function
Bernhard Antes et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Immunogenicity of therapeutic proteins. Part 3: Impact of manufacturing changes
Basant Sharma
BIOTECHNOLOGY ADVANCES (2007)
Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys
Andrew J. S. Jones et al.
GLYCOBIOLOGY (2007)
Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody
Chris Churnsae et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus
Ziping Wei et al.
ANALYTICAL CHEMISTRY (2007)
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients
Eiji Suzuki et al.
CLINICAL CANCER RESEARCH (2007)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
A role for protein misfolding in immunogenicity of biopharmaceuticals
Coen Maas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain
Keith A. Johnson et al.
ANALYTICAL BIOCHEMISTRY (2007)
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types
Yutaka Kanda et al.
GLYCOBIOLOGY (2007)
Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells
Barry Byrne et al.
DRUG DISCOVERY TODAY (2007)
Mapping and partial characterization of proteases expressed by a CHO production cell line
H. Sandberg et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: Biochemical and immunological studies
Zafar Rasheed et al.
LIFE SCIENCES (2006)
Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity
Hester A. Doyle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh et al.
NATURE BIOTECHNOLOGY (2006)
Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis
Himanshu S. Gadgil et al.
ANALYTICAL BIOCHEMISTRY (2006)
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
Leonard G. Presta
ADVANCED DRUG DELIVERY REVIEWS (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature
Hongcheng Liu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Modulation of therapeutic antibody effector functions by glycosylation engineering:: Influence of Golgi enzyme localization domain and co-expression of heterologous β1,4-N-acetylglucosaminyltransferase III and Golgi α-mannosidase II
C Ferrara et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Structural and functional characterization of glycosylation in an immunoglobulin G1 to Cryptococcus neoformans glucuronoxylomannan
F Wang et al.
MOLECULAR IMMUNOLOGY (2006)
Impact of variable domain glycosylation on antibody clearance: An LC/MS characterization
LH Huang et al.
ANALYTICAL BIOCHEMISTRY (2006)
Influence of aggregation on immunogenicity of recombinant human factor VIII in hemophilia A mice
VS Purohit et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity
Y Lyubarskaya et al.
ANALYTICAL BIOCHEMISTRY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins
Susan A. Brooks
EXPERT REVIEW OF PROTEOMICS (2006)
Confounding B-cell defences: lessons from a staphylococcal superantigen
GJ Silverman et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Glycosylation of recombinant antibody therapeutics
R Jefferis
BIOTECHNOLOGY PROGRESS (2005)
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides
R Niwa et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro
J Hodoniczky et al.
BIOTECHNOLOGY PROGRESS (2005)
Identification and characterization of deamidation sites in the conserved regions of human Immunoglobulin Gamma antibodies
D Chelius et al.
ANALYTICAL CHEMISTRY (2005)
Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry
LT Wang et al.
PHARMACEUTICAL RESEARCH (2005)
Characterization of a novel modification to monoclonal antibodies: Thioether cross-link of heavy and light chains
GI Tous et al.
ANALYTICAL CHEMISTRY (2005)
Non-enzymatic hinge region fragmentation of antibodies in solution
AJ Cordoba et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
In vivo deamidation characterization of monoclonal antibody by LC/MS/MS
LH Huang et al.
ANALYTICAL CHEMISTRY (2005)
Protein aggregation and its inhibition in biopharmaceutics
W Wang
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa
A Okazaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The clinical pharmacology of therapeutic monoclonal antibodies
LK Roskos et al.
DRUG DEVELOPMENT RESEARCH (2004)
Establishment of FUT8 knockout Chinese hamster ovary cells:: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity
N Yamane-Ohnuki et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1
MI Gómez et al.
NATURE MEDICINE (2004)
Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA
K Mori et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Structure-immunogenicity relationships of therapeutic proteins
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2004)
Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation?
Y Miwa et al.
XENOTRANSPLANTATION (2004)
Protease expression in the supernatant of Chinese Hamster Ovary cells grown in serum-free culture
P Elliott et al.
BIOTECHNOLOGY LETTERS (2003)
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants
K Nakajou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures
CT Yuen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans
SJ Hunter et al.
DIABETES (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterisation of endogenous retrovirus in rodent cell lines used for production of biologicals
AJ Shepherd et al.
BIOLOGICALS (2003)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Non-enzymatic glycation of IgG:: An in vivo study
A Lapolla et al.
HORMONE AND METABOLIC RESEARCH (2002)
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
N Casadevall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
Expression of GnTIII in a recombinant anti-CD20 CHO production cell line:: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FcγRIII
J Davies et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Sialylation of human IgG-Fc carbohydrate by transfected rat α2,6-sialyltransferase
R Jassal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Post-translational protein modifications in antigen recognition and autoimmunity
HA Doyle et al.
TRENDS IN IMMUNOLOGY (2001)
The α-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation
U Galili
BIOCHIMIE (2001)
Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells
KN Baker et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Development and characterization of novel erythropoiesis stimulating protein (NESP)
JC Egrie et al.
BRITISH JOURNAL OF CANCER (2001)
Identification of multiple sources of charge heterogeneity in a recombinant antibody
RJ Harris et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure
A Wright et al.
GLYCOBIOLOGY (2000)
Achievements and challenges of sialic acid research
R Schauer
GLYCOCONJUGATE JOURNAL (2000)
A new Chinese hamster ovary cell line expressing α2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins
A Bragonzi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics
TS Raju et al.
GLYCOBIOLOGY (2000)
Natural antibodies and the host immune responses to xenografts
DV Cramer
XENOTRANSPLANTATION (2000)
分享论文
